2016 Presidential Election: The Greatest CON In U.S. Electoral History . Two of the World's Most Infamous Snake Oil Salesmen Mesmerize Electorate USA Why were they each deliberately set up to be the lesser of the two evils for this 2016 ... Before It's News, 1 month ago
Lightship relies on MA onPC command wing South Africa - Lightship Productions, owned and run by the enterprising Ni-Lou Breytenbach, is the latest South African lighting production, design and delivery specialist to invest in MA Lighting control ...LSI Online, 1 month ago
Multi-gene test can help identify early breast cancer patients who can safely be spared chemotherapy
Researchers have shown for the first time that it is possible to use a multi-gene test to identify patients with early breast cancer who can be spared chemotherapy and who will still be alive and well five years after diagnosis. New results from ...News-Medical.Net, 1 month ago Multi-Gene Test Could Spare Early Breast Cancer Patients Chemo Medical Design Technology, 1 month ago Multi-gene test identifies early breast cancer patients who can be spared chemo Ecancer Medicalscience, 1 month ago EBCC-10 NEWS: Five-year results show 21-gene test successfully identifies early breast cancer patients who can be spared chemotherapy European Cancer Organisation, 1 month ago
Genomic Health : Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX® in Node-positive and High-risk Node-negative Breast Cancer
/PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced new five-year clinical outcomes results from a large PlanB study, which was highlighted as an oral presentation at the 10(th) European Breast Cancer Conference (EBCC-10)(1) in ...4 Traders, 1 month ago Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX® in Node-positive and High-risk Node-negative Breast Cancer Dutch Life Science Database, 1 month ago Genomic Health, Inc. Announces Five-Year Outcomes From International 'PlanB' Study Demonstrating The Clinical Utility Of Oncotype DX In Node-Positive And High-Risk Node-Negative Breast Cancer BioSpace, 1 month ago Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX® Barchart, 2 months ago
Five-year outcomes results from European 'PlanB' study show that breast cancer patients with low Oncotype DX®..
Genomic Health, Inc. (MM) (NASDAQ:GHDX) Intraday Stock Chart Today : Friday 11 March 2016 Study confirms the test's ability to accurately predict clinical outcomes, reinforcing the unique value of Oncotype DX as the only multi-gene breast ...ADVFN India, 1 month ago
More from: , Ariva.de...and 2 other sources
SAN JOSE, Calif.--(BUSINESS WIRE)--Mar. 10, 2016-- On March 30 th , 2016, Silicon Valley Forum's Women in Tech Festival is back for a second year with Women Around the Universe , a full-day celebration of the achievements and accomplishments of ...Bloomberg, 1 month ago
StockMarketWire.com - London equities closed firmly lower as big-ticket miners were pummelled further south as China trade data for February shocked the market, and traders began expressing concerns about the broadly heightened price of commodities.Stock Market Wire, 1 month ago
on your WebpageAdd Widget >Get your members hooked!